FDA Suspends Ixchiq Vaccine After 1.5 Years of Safety Data Showed Serious Risk

Aug-26-2025
On Aug. 25, the FDA informed the public that the agency officially suspended its approval for Valneva’s Ixchiq vaccine.
Ixchiq is a vaccine for Chikungunya, a mosquito-borne disease. The vaccine was initially approved to be administered in the United States in November 2023, under the FDA’s fast-tracked accelerated approval pathway.
Let’s go through what the data showed, as well as why the FDA decided this move to stop the vaccine was necessary.

Episode Resources:
🔵 FDA Update:
https://bit.ly/45T7U5c
🔵 The Adverse Events:


https://bit.ly/45AfSBn

FDA Suspends Ixchiq Vaccine After 1.5 Years of Safety Data Showed Serious Risk | Facts Matter
https://www.theepochtimes.com/epochtv/fda-suspends-ixchiq-vaccine-after-1-5-years-of-safety-data-showed-serious-risk-facts-matter-5906408